Aesculap Biologics, LLC Announces First Human Implantation of NOVOCART® 3D

Articular cartilage gives synovial joints friction-free movement with even load distribution to minimize peak stress on the bone. The loss or damage of articular cartilage can lead to osteoarthritis, the leading cause of chronic disability in the US.1 NOVOCART 3D aims to stop or slow down the deterioration of articular cartilage. NOVOCART 3D places healthy cartilage cells on a collagen-based scaffold grown from a small cartilage biopsy harvested from the patient. After a 21 – 25 day growth cycle, the final cell-scaffold is implanted into the cartilage defect, positioning the cells to grow into new cartilage tissue, with the intention of relieving pain and restoring normal function of the joint.

“This is a major milestone for Aesculap and the NOVOCART 3D technology,” said Chuck DiNardo, Aesculap, Inc. President. “The NOVOCART 3D technology offers great potential to provide cutting edge biologic solutions for our surgeons and their patients and will greatly enhance their quality of life.”

To learn more about the NOVOCART 3D clinical trial contact the Aesculap Biologics Study Coordinator at cathy.dawson@aesculap.com or visit: http://clinicaltrials.gov/show/NCT01957722

Learn more about Aesculap’s other offerings at aesculapusa.com

1 http://www.cdc.gov/chronicdisease/overview/index.htm

Dana Burns
Aesculap, Inc.
phone: 610-984-9242
mobile: 610-217-4964
email: dana.burns@aesculap.com 
twitter: @dburns_comm 

About Aesculap Biologics, LLC 
Aesculap Biologics, LLC, was established in January 2012 as a division of Aesculap, Inc. and is focused on biological approaches to the repair and regeneration of diseased or damaged tissues. Using a combination of cells, growth factors and smart biomaterial devices, Aesculap Biologics products can stimulate and support the synthesis of new tissue and enhance the body’s own regenerative power to improve the quality of patients lives.

Aesculap, Inc., a B. Braun company, is part of a 175-year-old global organization focused on meeting the needs of an ever-changing healthcare community.

Tags:

 About Us

Aesculap, Inc., a B. Braun company, is part of a 175-year-old global organization focused on meeting the needs of an ever-changing healthcare community. Through close collaboration with its customers, Aesculap provides advanced technologies for general surgery, neurosurgery, spine, ortho and closure technologies. Aesculap continues a proud heritage of leadership and responsiveness as we strive to deliver products and services that improve the quality of patients’ lives.